- Report
- April 2024
- 309 Pages
Global
From €4324EUR$4,499USD£3,708GBP
- Report
- June 2023
- 186 Pages
Global
From €5286EUR$5,500USD£4,533GBP
- Report
- March 2024
- 195 Pages
Global
From €3243EUR$3,374USD£2,781GBP
€3603EUR$3,749USD£3,090GBP
- Report
- May 2024
- 89 Pages
Global
From €5382EUR$5,600USD£4,616GBP
- Report
- February 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- February 2024
- 200 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- October 2023
- 147 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- October 2023
- 146 Pages
Global
From €3390EUR$3,528USD£2,907GBP
€3989EUR$4,150USD£3,421GBP
- Report
- July 2023
- 220 Pages
Global
€4609EUR$4,795USD£3,952GBP
- Report
- May 2024
- 114 Pages
Global
From €5382EUR$5,600USD£4,616GBP
- Report
- February 2024
- 120 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- February 2024
- 255 Pages
Global
From €4758EUR$4,950USD£4,080GBP
- Report
- May 2023
- 244 Pages
Global
From €5286EUR$5,500USD£4,533GBP
- Report
- March 2024
- 189 Pages
Global
From €3243EUR$3,374USD£2,781GBP
€3603EUR$3,749USD£3,090GBP
- Report
- January 2024
- 150 Pages
Global
From €5719EUR$5,950USD£4,904GBP
- Report
- October 2023
- 195 Pages
Global
From €5719EUR$5,950USD£4,904GBP
- Report
- February 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- December 2023
- 200 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- November 2023
- 178 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- October 2023
- 190 Pages
Global
From €4710EUR$4,900USD£4,039GBP
Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, such as cancer. Cancer markers are a type of biomarker that can be used to detect the presence of cancer in a patient. They can be used to diagnose, monitor, and predict the progression of cancer. Cancer markers can be proteins, hormones, enzymes, or other molecules that are produced by cancer cells or are associated with the presence of cancer.
Cancer markers are used in a variety of ways, including to detect the presence of cancer, to monitor the progression of the disease, and to predict the response to treatment. They can also be used to identify patients who are at risk for developing cancer.
The cancer marker market is a rapidly growing segment of the biomarker market. It is driven by the increasing prevalence of cancer, the development of new technologies for detecting and monitoring cancer, and the increasing demand for personalized medicine.
Companies in the cancer marker market include Abbott Laboratories, Agilent Technologies, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. Show Less Read more